MYROVLYTIS TECHNOLOGY VENTURES LTD has a total of 14 patent applications. Its first patent ever was published in 2010. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ADURO BIOTECH INC, INIMMUNE CORP and NOVARTIS VACCINES & DIAGNOSTICS SRL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Computer technology | |
#5 | Foods and drinks | |
#6 | Surface technology and coating |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Sugars | |
#4 | Peptides | |
#5 | Computational chemistry | |
#6 | Single-crystal-growth | |
#7 | Enzymes | |
#8 | Microorganisms | |
#9 | Bioinformatics |
# | Name | Total Patents |
---|---|---|
#1 | Lu Xiaohong | 5 |
#2 | Maher Eamonn | 5 |
#3 | Tee Andrew | 3 |
#4 | Baar Keith | 3 |
#5 | Nookala Ravi | 2 |
#6 | Xiaohong Lu | 1 |
#7 | Eamonn Maher | 1 |
Publication | Filing date | Title |
---|---|---|
GB201202870D0 | Screening methods | |
GB201107825D0 | Compositions/substances for the treatment of renal cell carcinoma | |
WO2011132001A1 | Crystal structure | |
GB201021429D0 | Crystal structure | |
GB201006722D0 | Crystals of folliculin C-terminus | |
GB201003894D0 | A composition for use in the treatment of Birt-Hogg-Dubô sydrome | |
GB201002773D0 | Composition for the treatment of renal cell carcinoma |